schaftoside has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Liu, C; Liu, M; Mi, S; Song, M; Wang, J; Wu, S; Zhang, G | 1 |
1 other study(ies) available for schaftoside and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
Topics: Animals; Cell Line, Tumor; Cholesterol; Diet, High-Fat; Disease Models, Animal; Glycosides; Hepatocytes; Humans; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Triglycerides; Up-Regulation | 2020 |